Kyle Kampman, MD
Enriched profileProfessor of Psychiatry, Perelman School of Medicine; Medical Director, Penn Center for Studies of Addiction · University of Pennsylvania
Kyle Kampman is Professor of Psychiatry, Perelman School of Medicine; Medical Director, Penn Center for Studies of Addiction at University of Pennsylvania. OpenAlex indexes 188 publications with 10,347 citations (h-index 57); ClinicalTrials.gov lists 18 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Kyle Kampman, MD, is Professor of Psychiatry, Perelman School of Medicine at University of Pennsylvania. The public record shows 188 publications with 10,347 citations (h-index 57), centered on Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, Neurotransmitter Receptor Influence on Behavior. It also documents an investigator role on 18 registered clinical trials, 17 NIH-funded awards (1995–2025).
- Most recent indexed publication: 2019 · Science advances
- Top research focus: Substance Abuse Treatment and Outcomes
- 18 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 117.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Brenipatide in Participants With Opioid Use Disorder
Sponsor: Eli Lilly and Company
- Effect of Nutritional Ketosis on Alcohol Metabolism
Sponsor: University of Pennsylvania
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Sponsor: University of Pennsylvania
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 16 Oct 2026
17 NIH research awards on record, funded 1995–2025 per NIH RePORTER. The latest:
- Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
University of Pennsylvania
FY2025$2,584,873UH3DA049694 - Psilocybin: Capturing brain mechanisms of motivation and neurocognition in individuals with opioid use disorder
University of Pennsylvania
FY2025$472,087R61DA061206 - Rapid outpatient low-dose initiation of buprenorphine for individuals with OUD using fentanyl
University of Pennsylvania
FY2025$230,000R34DA057507
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01
- 02A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine DependenceArticle392 citations2004
- 03The Status of DisulfiramArticle380 citations2006
- 04
- 05A pilot trial of topiramate for the treatment of cocaine dependenceArticle315 citations2004
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/kyle-kampman-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Editorial & leadership roles
journal and society appointments- Chair
ASAM committee that wrote the National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Secondary affiliations
appointments beyond the home institution- Addiction Recovery Unit
Philadelphia VA Medical Center (treating clinician)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →trappedcast.buzzsprout.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →penntoday.upenn.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Nabila Dahodwala, MD
University of Pennsylvania
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center